Literature DB >> 10052684

Screening of serum autoantibodies to cardiac beta1-adrenoceptors and M2-muscarinic acetylcholine receptors in 408 healthy subjects of varying ages.

H R Liu1, R R Zhao, J M Zhi, B W Wu, M L Fu.   

Abstract

Autoantibodies to cardiac beta1-adrenoceptors and M2-muscarinic receptors have mainly been found in the sera of patients with idiopathic dilated cardiomyopathy (DCM). In order to elucidate the pathological significance of these autoantibodies in DCM, it is necessary to understand their characteristic distribution in a healthy population of different genders and ages. The peptides corresponding to the sequences of the second extracellular loops of the human beta1-adrenoceptor and M2-muscarinic receptors were therefore used as antigens to screen the sera of 408 healthy subjects of different ages (ranging from 0.5 to 85 years). Of 408 sera, 41 (10.0%) and 46 (11.3%) recognized the beta1-adrenoceptor and M2-muscarinic receptor peptides respectively. Of the positive sera for beta1-adrenoceptors and M2-muscarinic receptors, up to 63.4% and 56.5% had both anti-beta1-adrenoceptor and anti-M2-muscarinic receptor autoantibodies respectively. The antibody titres of the positive sera of healthy subjects were all of a low level, with a geometric mean titre of 1:42+/-1.9 for anti-beta1-adrenoceptor antibodies and 1:51+/-1.7 for anti-M2-muscarinic receptor antibodies. The frequency of occurrence of autoantibodies to both receptors in the sera of healthy subjects increased significantly with age. In conclusion, the autoantibodies to beta1-adrenoceptors and M2-muscarinic receptors in the sera of healthy subjects are characterized by a low frequency of occurrence and low titre, with the frequency of occurrence increasing with age.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10052684     DOI: 10.3109/08916939908995971

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  24 in total

Review 1.  The clinical significance of anti-beta-1 adrenergic receptor autoantibodies in cardiac disease.

Authors:  Udi Nussinovitch; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2013-02       Impact factor: 8.667

Review 2.  The diagnostic and clinical significance of anti-muscarinic receptor autoantibodies.

Authors:  Udi Nussinovitch; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2012-06       Impact factor: 8.667

3.  Agonistic autoantibodies as vasodilators in orthostatic hypotension: a new mechanism.

Authors:  Hongliang Li; David C Kem; Sean Reim; Muneer Khan; Megan Vanderlinde-Wood; Caitlin Zillner; Daniel Collier; Campbell Liles; Michael A Hill; Madeleine W Cunningham; Christopher E Aston; Xichun Yu
Journal:  Hypertension       Date:  2012-01-03       Impact factor: 10.190

4.  Th17 cells facilitate the humoral immune response in patients with acute viral myocarditis.

Authors:  Jing Yuan; Ai-Lin Cao; Miao Yu; Qiong-Wen Lin; Xian Yu; Jing-Hui Zhang; Min Wang; He-Ping Guo; Yu-Hua Liao
Journal:  J Clin Immunol       Date:  2009-12-10       Impact factor: 8.317

5.  Activating autoantibodies to the beta-1 adrenergic and m2 muscarinic receptors facilitate atrial fibrillation in patients with Graves' hyperthyroidism.

Authors:  Stavros Stavrakis; Xichun Yu; Eugene Patterson; Shijun Huang; Sean R Hamlett; Laura Chalmers; Reji Pappy; Madeleine W Cunningham; Syed A Morshed; Terry F Davies; Ralph Lazzara; David C Kem
Journal:  J Am Coll Cardiol       Date:  2009-09-29       Impact factor: 24.094

6.  Opposing cardiac effects of autoantibody activation of β-adrenergic and M2 muscarinic receptors in cardiac-related diseases.

Authors:  Stavros Stavrakis; David C Kem; Eugene Patterson; Pedro Lozano; Shijun Huang; Bela Szabo; Madeleine W Cunningham; Ralph Lazzara; Xichun Yu
Journal:  Int J Cardiol       Date:  2010-01-06       Impact factor: 4.164

Review 7.  Drug-like actions of autoantibodies against receptors of the autonomous nervous system and their impact on human heart function.

Authors:  L R Herda; S B Felix; F Boege
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

8.  Impact of human autoantibodies on β1-adrenergic receptor conformation, activity, and internalization.

Authors:  Beatrice Bornholz; Stefanie Weidtkamp-Peters; Stephanie Schmitmeier; Claus A M Seidel; Lars R Herda; Stephan B Felix; Horst Lemoine; Jürgen Hescheler; Filomain Nguemo; Christoph Schäfer; Morten O Christensen; Christian Mielke; Fritz Boege
Journal:  Cardiovasc Res       Date:  2012-12-03       Impact factor: 10.787

9.  β1-Adrenoceptor autoantibodies from DCM patients enhance the proliferation of T lymphocytes through the β1-AR/cAMP/PKA and p38 MAPK pathways.

Authors:  Yunhui Du; Li Yan; Jin Wang; Wenzhang Zhan; Kai Song; Xue Han; Xiao Li; Jimin Cao; Huirong Liu
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

Review 10.  Immune-mediated and autoimmune myocarditis: clinical presentation, diagnosis and management.

Authors:  Alida L P Caforio; Renzo Marcolongo; Roland Jahns; Michael Fu; Stephan B Felix; S Iliceto
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.654

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.